Actinium Pharmaceuticals, Inc. (ATNM): Net Income
-$33.89M
Year ended 2025-12-31
$11.31M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$33.89M | n/m | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | -$38.24M | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | -$48.82M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$33.02M | n/m | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | -$24.77M | n/m | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$22.21M | n/m | 2022-03-25, From 2020-01-01 |
| 2019-12-31 | -$21.90M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$23.65M | n/m | 2020-05-08, From 2018-01-01 |
| 2017-12-31 | -$26.60M | n/m | 2019-03-15, From 2017-01-01 |
| 2016-12-31 | -$24.32M | n/m | 2019-03-15, From 2016-01-01 |
| 2015-12-31 | -$21.03M | n/m | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | -$24.69M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$10.77M | n/m | 2016-03-11, From 2013-01-01 |
| 2012-12-31 | -$8.36M | n/m | 2014-02-28, From 2012-01-01 |
| 2011-12-31 | -$3.44M | n/m | 2014-02-28, From 2011-01-01 |
| 2010-12-31 | -$467.3K | n/m | 2014-02-28, From 2010-01-01 |
| 2009-12-31 | -$3.43M | n/m | 2014-02-28, From 2009-01-01 |
| 2008-12-31 | -$5.57M | n/m | 2014-02-28, From 2008-01-01 |
| 2007-12-31 | -$5.62M | n/m | 2014-02-28, From 2007-01-01 |
| 2006-12-31 | -$6.05M | n/m | 2014-02-28, From 2006-01-01 |
| 2005-12-31 | -$4.58M | n/m | 2014-02-28, From 2005-01-01 |
| 2004-12-31 | -$5.73M | n/m | 2014-02-28, From 2004-01-01 |
| 2003-12-31 | -$3.53M | n/m | 2014-02-28, From 2003-01-01 |
| 2002-12-31 | -$3.19M | n/m | 2014-02-28, From 2002-01-01 |
| 2001-12-31 | -$5.09M | n/a | 2014-02-28, From 2001-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | -$33.89M | n/m |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | -$46.88M | n/m |
| iBio, Inc. (IBIO) | 2026-06-30 | -$33.04M | n/m |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | -$4.23M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | -$6.50M | n/m |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | -$84.95M | n/m |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | -$55.48M | n/m |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | -$19.18M | n/m |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | -$78.26M | n/m |
Compare ATNM, IXHL, IBIO, SILO side by side · Screen every company in Pharmaceutical Preparations ↗